Gilead Sciences
GILD
#105
Rank
S$224.05 B
Marketcap
S$180.57
Share price
1.72%
Change (1 day)
39.73%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2025 (TTM): S$12.94 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are S$29.08 Billion. In 2024 the company made an earning of S$0.87 Billion a decrease over its 2023 earnings that were of S$8.72 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) S$12.94 B1374.77%
2024 S$0.87 B-89.94%
2023 S$8.72 B17.97%
2022 S$7.39 B-29.77%
2021 S$10.53 B395.99%
2020 S$2.12 B-67.66%
2019 S$6.56 B-33.84%
2018 S$9.92 B-42.35%
2017 S$17.21 B-20.87%
2016 S$21.74 B-21.06%
2015 S$27.55 B45.8%
2014 S$18.89 B253.01%
2013 S$5.35 B16.51%
2012 S$4.59 B-1.07%
2011 S$4.64 B-6.71%
2010 S$4.97 B11.75%
2009 S$4.45 B29.5%
2008 S$3.44 B19.11%
2007 S$2.88 B-455.74%
2006 -S$0.82 Billion-154.93%
2005 S$1.47 B76.99%
2004 S$0.83 B-266.16%
2003 -S$0.51 Billion-638.24%
2002 S$93.36 M31.5%
2001 S$71 M-242.15%
2000 -S$49.96 Million-40.2%
1999 -S$83.53 Million31.85%
1998 -S$63.36 Million8.73%
1997 -S$58.27 Million27.22%
1996 -S$45.8 Million
1994 -S$43.64 Million26.57%
1993 -S$34.48 Million46.49%
1992 -S$23.54 Million362.5%
1991 -S$5.09 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$41.21 B 227.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$15.07 B 19.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$2.11 B-83.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$28.62 B 127.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$10.48 B-16.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.42 B-80.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$1.26 B-89.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$5.67 B-54.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$29.37 B 133.56%๐Ÿ‡บ๐Ÿ‡ธ USA